ArticleOncology and therapy2024

Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) FL with CAR-T Cell Therapy: A Vodcast and Case Example.

Kai HübelPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.